BEVACIZUMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 166 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for Prostate cancer.
Most Reported Side Effects for BEVACIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,094 | 15.5% | 3,560 | 1,814 |
| Death | 8,493 | 10.9% | 8,485 | 726 |
| Diarrhoea | 4,911 | 6.3% | 1,110 | 1,932 |
| Disease progression | 4,653 | 6.0% | 1,838 | 749 |
| Fatigue | 4,572 | 5.9% | 1,358 | 1,294 |
| Nausea | 4,357 | 5.6% | 1,050 | 1,459 |
| Hypertension | 4,309 | 5.5% | 534 | 1,181 |
| Anaemia | 3,221 | 4.1% | 587 | 1,289 |
| Vomiting | 3,193 | 4.1% | 794 | 1,404 |
| Neutropenia | 2,875 | 3.7% | 449 | 720 |
| Pyrexia | 2,602 | 3.3% | 512 | 1,618 |
| Decreased appetite | 2,559 | 3.3% | 682 | 944 |
| Asthenia | 2,489 | 3.2% | 790 | 924 |
| Drug ineffective | 2,488 | 3.2% | 493 | 369 |
| Proteinuria | 2,384 | 3.1% | 325 | 459 |
Other Indications for BEVACIZUMAB
Product used for unknown indication (9,041)
Hepatocellular carcinoma (7,773)
Colorectal cancer metastatic (5,474)
Ovarian cancer (5,283)
Non-small cell lung cancer (4,136)
Colon cancer (4,015)
Colorectal cancer (2,788)
Breast cancer (2,130)
Lung neoplasm malignant (1,810)
Glioblastoma (1,610)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)